This was the stock's third consecutive day of losses.

Cannabis Giant Tilray Doubles Down On Its Beer Business ... With speculation around the Trump administration’s tariffs and potential price hikes, MarketBeat Electronic Arts Posts Upbeat Earnings ...

maintained the forecast for Tilray's fiscal year 2025 sales at $900 million but revised the FY25 EBITDA estimate downward to $62 million. Azer also adjusted the price target on Tilray shares ...

Canaccord Genuity Group’s price target suggests a potential ... As a group, equities research analysts forecast that Tilray will post -0.14 earnings per share for the current fiscal year.

Management maintained its forecast for revenues during the ... Street analysts are still fairly positive on Tilray. The average price target is currently $1.87, which would imply more than 58% ...

Shares of Tilray Brands (NASDAQ: TLRY) were flying higher on Wednesday. The company's stock gained 7.5% as of 2:25 p.m. ET but gained as much as 20% earlier in the day. The leg up comes as the S&P ...

Medical announced the expansion of its medical cannabis extract portfolio in Germany. Tilray’s new medical cannabis offerings in ...

Tilray Brands, Inc. (“Tilray” or “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, today ...

We forecast mid-single-digit organic growth ... The existence of the illicit market limits the potential price increases Tilray can push through to consumers. Governments are incentivized to ...

The settlement could finally close the chapter on a five-year-old lawsuit alleging Tilray insiders secretly profited from ...